Stomach Cancer Trial, Recruiting NCT06940102 Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. Condition: Stomach Cancer
Back to Stomach Cancer

Stomach Cancer Trial, Recruiting

NCT06940102
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are willing and able to sign a written consent form to take part.
  • People who are 18 years of age or older at the time of joining.
  • People whose general physical functioning is reasonably well preserved (rated on a standard scale used by doctors to measure how cancer affects daily activity — confirm with trial site).
  • People whose life expectancy is at least 3 months.
  • People who have been confirmed through tissue or cell testing to have an advanced or spreading cancer originating in the digestive system that cannot be cured.
  • People whose cancer cannot be treated with local treatments such as surgery, targeted heat or cold therapy, or chemotherapy delivered directly to the tumour, and who are planned to receive a type of targeted drug treatment (called a TKI), possibly combined with chemotherapy or immunotherapy.
  • People who meet recognised medical criteria for early-stage or established cancer-related weight loss and muscle loss (a condition known as cachexia or pre-cachexia — confirm with trial site).
  • People whose major organ functions (such as kidneys and liver) are working at an acceptable level as determined by the treating doctor.

Who may not be able to join:

  • People who have a blockage in their digestive tract.
  • People whose reduced appetite or poor eating is caused by a nerve condition, mental health condition, or pain rather than by cancer.
  • People who have serious existing conditions affecting the brain and blood vessels, heart, kidneys, or liver.
  • People who have had a major surgery or significant physical injury within the past month.
  • People who have a known allergy to any ingredient in the study drug.
  • People whom the trial doctor considers unsuitable for any other reason.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Cheng Du, The General Hospital of Northern Theater Command

Phone: 024-28851942

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Changchun GeneScience Pharmaceutical Co., Ltd.
Registry
ClinicalTrials.gov
Start date
12 March 2025
Est. completion
1 March 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Appetite improvement level; Weight improvement level

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov